calcified parenchymal central nervous system cysticercosis and clinical outcomes in epilepsy objective this study aimed to compare clinical outcomes including seizure frequency and psychiatric symptoms between patients with epilepsy with neuroimaging evidence of past brain parenchymal neurocysticercosis infection patients with other structural brain lesions and patients without structural neuroimaging abnormalitiesmaterial and methods the study included retrospective crosssectional analysis of all patients treated for epilepsy in a communitybased adult neurology clinic during a threemonth periodresults a total of 160 patients were included in the analysis including 63 with neuroimaging findings consistent with past parenchymal neurocysticercosis infection 55 with structurally normal brain neuroimaging studies and 42 with other structural brain lesions no significant differences were detected between groups for either seizure freedom 4603 5091 and 4762 respectively p0944 or mean seizure frequency per month mean250 sd81 mean483 sd1764 mean855 sd2731 respectively p0267 selfreported depressive symptoms were more prevalent in those with parenchymal neurocysticercosis than in the other groups p0003 no significant differences were detected for prevalence of selfreported anxiety or psychotic symptomsconclusions calcified parenchymal neurocysticercosis results in refractory epilepsy about as often as other structural brain lesions depressive symptoms may be more common among those with epilepsy and calcified parenchymal neurocysticercosis consequently screening for depression may be indicated in this population